- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
- Premium Tools
- Real Money
- Real Money Pro
- Action Alerts PLUS
- Stocks Under $10
- Breakout Stocks
- Options Profits
Latest Commentary
Real Money: Independent market insight from a veteran team of trusted Wall Street pros.
• Up-to-the-minute reports on market activity
• Actionable trade ideas
• Up-to-the-minute reports on market activity
• Actionable trade ideas
Latest Strategies
Real Money Pro: Professional tools and specific trade ideas for active investors.
• Information-packed market flow providing trade ideas, fast
• Dynamic interface with professional-grade analytical tools
• Full, unlimited access to Real Money
• Information-packed market flow providing trade ideas, fast
• Dynamic interface with professional-grade analytical tools
• Full, unlimited access to Real Money
Latest Alert
May 24, 2013 | 06:41 PM EDT
We remain overweight in industrials, materials, energy and financials. FULL ALERT »
Action Alerts PLUS: Jim Cramer and Stephanie Link actively manage a real money portfolio for Jim's charitable trust.
• Timely trade alerts including price targets
• Unique insight into market movements
• Guidance on how to trade right alongside Jim and Stephanie
• Timely trade alerts including price targets
• Unique insight into market movements
• Guidance on how to trade right alongside Jim and Stephanie
Latest Alert
May 24, 2013 | 04:28 PM EDT
As stocks ended their four-week winning streak this week, we used the volatility to trim one model portfolio position. FULL ALERT »
Stocks Under $10: David Peltier manages a portfolio of affordable stocks with huge upside potential.
• Identify fast-growing small-cap stock opportunities
• Buy and sell alerts allow you to analyze overlooked opportunities quickly
• In-depth reports and research packed with proprietary analysis
• Identify fast-growing small-cap stock opportunities
• Buy and sell alerts allow you to analyze overlooked opportunities quickly
• In-depth reports and research packed with proprietary analysis
Latest Alert
May 24, 2013 | 08:41 AM EDT
This name issued a near-perfect fiscal third-quarter earnings report and bumped its full-year guidance higher. FULL ALERT »
Breakout Stocks: Bryan Ashenberg, CFA, manages a portfolio of small and mid-cap stocks with high growth potential.
• Identify industry-changing macrotrends in their infancy
• Timely trade alerts loaded with detailed research
• Frequent communication about all Bryan's portfolio holdings
• Identify industry-changing macrotrends in their infancy
• Timely trade alerts loaded with detailed research
• Frequent communication about all Bryan's portfolio holdings
Latest Commentary
Options Profits: Day in and day out, our team of professional options traders search for inventive plays for trading spikes in market activity, emerging trends, and breaking news and events. These veterans reveal all their charts and technical data — delivering daily strategies and insightful commentary written specifically for the options trader plus 40 options trade ideas per week!
Myriad Genetics Inc. (MYGN)
MYGN (NASDAQ:Diversified Services)
$31.43
-0.76
-2.36%
Today's Range: 31.02 - 32.02 |
MYGN Avg Daily Volume: 1,179,200
| Last Update: 05/24/13 - 4:00 PM EDT |
| Volume: 1,104,565 |
| YTD Performance: 18.13% |
| Open: $32.02 |
| Previous Close: $32.19 |
| 52 Week Range: $22.02 - $34.70 |
| Oustanding Shares: 79,654,860 |
| Market Cap: 2,564,089,943 |
Analysts Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Strong Buy | 5 | 6 | 7 | 7 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 |
| Mean Rec. | 2.18 | 2.08 | 2.00 | 2.00 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (06/13) | FY (06/14) | |
|---|---|---|---|---|
| Average Estimate | $0.43 | $0.43 | $1.66 | $1.86 |
| Number of Analysts | 9 | 4 | 8 | 8 |
| High Estimate | $0.45 | $0.45 | $1.68 | $2.00 |
| Low Estimate | $0.40 | $0.37 | $1.65 | $1.60 |
| Prior Year | $0.34 | $0.36 | $1.30 | $1.66 |
| Growth Rate (Year over Year) | 25.82% | 18.75% | 28.08% | 11.71% |
StockSignaling: 25 Stocks To Watch: http://t.co/Vtx6dLy0Nw : $PG $CBST $CPB $FANG $STZ $ERF $BSX $WCRX $ABCO $MYGN $SREV $FST $PRLB $CONN $MGM #nasdaq #spy
5 hours ago from Stock Signaling
5 hours ago from Stock Signaling
Hisurfexp: RT @StockSignaling: Upgraded Stocks Trading in a New Range: $TWO $WETF $DHX $AMAT $NOC $BEAM $FANG $ALTR $APO $URI $BMR $GVA $MYGN $ABCO $PCP #daytrader #spy
24 hours ago from Twitter for BlackBerry®
24 hours ago from Twitter for BlackBerry®
StockSignaling: Upgraded Stocks Trading in a New Range: $TWO $WETF $DHX $AMAT $NOC $BEAM $FANG $ALTR $APO $URI $BMR $GVA $MYGN $ABCO $PCP #daytrader #spy
1 day ago from Stock Signaling
1 day ago from Stock Signaling
StockSignaling: Upgraded Stocks Trading in a New Range: $TWO $WETF $DHX $AMAT $NOC $BEAM $FANG $ALTR $APO $URI $BMR $GVA $MYGN $ABCO $PCP #markets #trader
1 day ago from Stock Signaling
1 day ago from Stock Signaling
micenter: Myriad Genetics $MYGN Showing Bullish Technicals With Resistance At $32.88 ( http://t.co/UTFUQQjKF2 )
1 day ago from Marketintelligencecenter.com
1 day ago from Marketintelligencecenter.com
REWCapital: I'm SHORT: $CAVM $CXW $FAF $FSLR $INFI $MYGN $SHLD $UNXL $VHC $WAC #CNBC @rbdadaptive @bryanhldn1
1 day ago from web
1 day ago from web
StockSignaling: Upgraded Stocks Active in Pre-Market: $AMAT $FANG $WCRX $DNDN $LPSN $XOMA $VCLK $MYGN $MELI $ABFS $LINE $AGNC $AVEO $PKT $ARNA #spy #nyse
1 day ago from Stock Signaling
1 day ago from Stock Signaling
medstudentrader: RT @pelias01: 6 Ways You Can Profit From Molecular Diagnostics http://t.co/fP0hRE9Upu $EXAS $GHDX $ILMN $LLY $MYGN $NSPH $QGEN $SQNM
1 day ago from Twitter for Mac
1 day ago from Twitter for Mac
1gecko2014: RT @pelias01: 6 Ways You Can Profit From Molecular Diagnostics http://t.co/fP0hRE9Upu $EXAS $GHDX $ILMN $LLY $MYGN $NSPH $QGEN $SQNM
1 day ago from Twitter for iPhone
1 day ago from Twitter for iPhone
pelias01: 6 Ways You Can Profit From Molecular Diagnostics http://t.co/fP0hRE9Upu $EXAS $GHDX $ILMN $LLY $MYGN $NSPH $QGEN $SQNM
1 day ago from Tweet Button
1 day ago from Tweet Button
Here is my compilation of last night's profit reports.
Myriad Genetics numbers cut at Credit Suisse
Shares of MYGN now seen reaching $28, according to Credit Suisse. Estimates also reduced, given lower Medicare reimbursement rates. Neutral rating.
Myriad Genetics downgraded at JP Morgan
MYGN was downgraded to Underweight, JP Morgan said. Supreme Court ruling on ACLU case may hang over the stock.
At least the uptrend is still intact.
Myriad Genetics upgraded at BofA/Merrill
MYGN was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $32 price target. Company can continue to diversify and expand its business.
Myriad Genetics rated new Neutral at Credit Suisse
MYGN was initiated with a Neutral rating, Credit Suisse said. $28 price target. Near and long term concerns overshadow underlying organic growth.
Myriad Genetics upgraded at Leerink
MYGN was upgraded from Market Perform to Outperform, Leerink Swann said. Reimbursement and IP fears appear overdone.
Myriad Genetics rated new Neutral at BofA Merrill
MYGN was initiated with a Neutral rating, Bank of America Merrill Lynch said. $28 price target. Shares appear fairly valued given uncertainties.
Myriad Genetics numbers raised at Oppenheimer
Shares of MYGN now seen reaching $29, Oppenheimer said. Estimates also raised on another solid beat and raise. Perform rating.
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.
IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.
IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.
© 2013 TheStreet, Inc. All rights reserved.